Form 4 for BSX Boston Scientific
Accepted 2022-12-14 00:00:00 ET · period of report 2022-12-13 · accession 0001225208-22-012777 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-12-14 | 2022-12-13 | BSX | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | S - Sale+OE | $47.78 | -79.3K | 216.9K | -27% | -$3.79M |
| D | 2022-12-14 | 2022-07-29 | BSX | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | G - Gift | $0.00 | -1,000 | 216.9K | -0.5% | $0 |
| D | 2022-12-14 | 2022-12-13 | BSX | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | M - OptEx | $7.39 | +79.3K | 296.1K | +37% | +$585.8K |
| D | 2022-12-14 | 2022-12-13 | BSX | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | M - OptEx | $0.00 | -79.3K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-12-13 | S | D | 79,264 | $47.78 | 216,871 | D | — | — | |
| 2 | Common | Common Stock | 2022-07-29 | G | D | 1,000 | $0.00 | 216,871 | D | — | — | |
| 3 | Common | Common Stock | 2022-12-13 | M | A | 79,264 | $7.39 | 296,135 | D | — | — | |
| 4 | Derivative | Stock Option (Right to Buy) | 2022-12-13 | M | D | 79,264 | $0.00 | 0 | D | $7.39 · — to 2023-02-28 | 79,264 Common Stock | (F4) Grant to the reporting person of an option to purchase a specified number of shares of common stock vesting in four equal annual installments beginning on February 28, 2014, the first anniversary of the date of grant. |